The Diagnostic Accuracy in Sepsis Act of 2025 amends Medicare rules to classify blood culture contamination as a hospital-acquired condition starting in fiscal year 2026. This means hospitals will be held accountable for blood culture contamination under Medicare's quality and safety standards, similar to other hospital-acquired infections. The bill requires the Secretary of Health and Human Services to establish a measure defining acceptable contamination rates, setting a benchmark that hospitals should not exceed a 1 percent contamination rate. The legislation affects all Medicare-participating hospitals and aims to improve the accuracy of sepsis diagnosis by reducing contamination in blood cultures, which can lead to misdiagnosis and unnecessary antibiotic use. No specific new funding is appropriated in the bill; instead, it creates a new performance metric that hospitals must meet to comply with existing Medicare quality standards.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.